212 related articles for article (PubMed ID: 23713337)
1. [Ozurdex, modern therapy for macular edema in central retinal vein occlusion].
Blajan C; Nicula D
Oftalmologia; 2012; 56(3):40-5. PubMed ID: 23713337
[TBL] [Abstract][Full Text] [Related]
2. [Dexamethason implant in the treatment of macular edema in retinal vein occlusion and intraocular inflammatory disease].
Brunner M; Haueter I; Valmaggia C
Klin Monbl Augenheilkd; 2013 Apr; 230(4):396-400. PubMed ID: 23629790
[TBL] [Abstract][Full Text] [Related]
3. Ozurdex in the management of the macular edema following retinal vein occlusion in clinical practice.
Matonti F; Meyer F; Guigou S; Barthelemy T; Dumas S; Gobert F; Hajjar C; Merite PY; Parrat E; Rouhette H; Pommier S
Acta Ophthalmol; 2013 Nov; 91(7):e584-6. PubMed ID: 23764276
[No Abstract] [Full Text] [Related]
4. Combination therapy with dexamethasone intravitreal implant and macular grid laser in patients with branch retinal vein occlusion.
Pichi F; Specchia C; Vitale L; Lembo A; Morara M; Veronese C; Ciardella AP; Nucci P
Am J Ophthalmol; 2014 Mar; 157(3):607-15.e1. PubMed ID: 24528934
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal dexamethasone implant for the treatment of macular edema after retinal vein occlusion in a clinical setting.
Ferrini W; Ambresin A
Klin Monbl Augenheilkd; 2013 Apr; 230(4):423-6. PubMed ID: 23629796
[TBL] [Abstract][Full Text] [Related]
6. Compassionate use of dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion in a clinical setting.
Parodi MB; Iacono P; Cascavilla M; Zucchiatti I; Bandello F
Acta Ophthalmol; 2012 Jun; 90(4):e322-3. PubMed ID: 21939501
[No Abstract] [Full Text] [Related]
7. Evolution of vitreomacular traction following the use of the dexamethasone intravitreal implant (Ozurdex) in the treatment of macular edema secondary to central retinal vein occlusion.
Bakri SJ; Omar AF
J Ocul Pharmacol Ther; 2012 Oct; 28(5):547-9. PubMed ID: 22537269
[TBL] [Abstract][Full Text] [Related]
8. Comparison of intravitreal bevacizumab upload followed by a dexamethasone implant versus dexamethasone implant monotherapy for retinal vein occlusion with macular edema.
Mayer WJ; Remy M; Wolf A; Kook D; Kampik A; Ulbig M; Reznicek L; Haritoglou C
Ophthalmologica; 2012; 228(2):110-6. PubMed ID: 22739239
[TBL] [Abstract][Full Text] [Related]
9. Impact of intravitreal dexamethasone implant (Ozurdex) on macular morphology and function.
Querques G; Lattanzio R; Querques L; Triolo G; Cascavilla ML; Cavallero E; Del Turco C; Casalino G; Bandello F
Retina; 2014 Feb; 34(2):330-41. PubMed ID: 23945638
[TBL] [Abstract][Full Text] [Related]
10. Onset and duration of visual acuity improvement after dexamethasone intravitreal implant in eyes with macular edema due to retinal vein occlusion.
Kuppermann BD; Haller JA; Bandello F; Loewenstein A; Jiao J; Li XY; Whitcup SM
Retina; 2014 Sep; 34(9):1743-9. PubMed ID: 24830824
[TBL] [Abstract][Full Text] [Related]
11. Effect of the duration of macular edema on clinical outcomes in retinal vein occlusion treated with dexamethasone intravitreal implant.
Yeh WS; Haller JA; Lanzetta P; Kuppermann BD; Wong TY; Mitchell P; Whitcup SM; Kowalski JW
Ophthalmology; 2012 Jun; 119(6):1190-8. PubMed ID: 22361318
[TBL] [Abstract][Full Text] [Related]
12. The Effect of Age on Dexamethasone Intravitreal Implant (Ozurdex®) Response in Macular Edema Secondary to Branch Retinal Vein Occlusion.
Altunel O; Göktaş A; Duru N; Özköse A; Arifoğlu HB; Ataş M
Semin Ophthalmol; 2018; 33(2):179-184. PubMed ID: 27599562
[TBL] [Abstract][Full Text] [Related]
13. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion.
Haller JA; Bandello F; Belfort R; Blumenkranz MS; Gillies M; Heier J; Loewenstein A; Yoon YH; Jacques ML; Jiao J; Li XY; Whitcup SM;
Ophthalmology; 2010 Jun; 117(6):1134-1146.e3. PubMed ID: 20417567
[TBL] [Abstract][Full Text] [Related]
14. DEXAMETHASONE IMPLANT FOR MACULAR EDEMA SECONDARY TO CENTRAL RETINAL VEIN OCCLUSION IN PATIENTS YOUNGER THAN 50 YEARS.
Battaglia Parodi M; Iacono P; Sacconi R; Parravano M; Varano M; Bandello F
Retina; 2015 Jul; 35(7):1381-6. PubMed ID: 26102437
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone intravitreal implants for retinal vein occlusion in a clinical setting.
Krivosic V; Bheekee A; Michée S; Delyfer MN; Tadayoni R; Korobelnik JF
Acta Ophthalmol; 2014 Nov; 92(7):e584-5. PubMed ID: 24629069
[No Abstract] [Full Text] [Related]
16. Intravitreal versus retrobulbar injections of triamcinolone for macular edema associated with branch retinal vein occlusion.
Hayashi K; Hayashi H
Am J Ophthalmol; 2005 Jun; 139(6):972-82. PubMed ID: 15953425
[TBL] [Abstract][Full Text] [Related]
17. [A cost-effectiveness study of dexamethasone implants in macular edema].
Lozano López V; Serrano García M; Mantolán Sarmiento C; Pareja Ríos A; Losada Castillo MJ; Cordovés Dorta L; Quijada Fumero E; Virgós Aller T; Bullejos Molina M
Arch Soc Esp Oftalmol; 2015 Jan; 90(1):14-21. PubMed ID: 25443181
[TBL] [Abstract][Full Text] [Related]
18. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
Ding X; Li J; Hu X; Yu S; Pan J; Tang S
Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
[TBL] [Abstract][Full Text] [Related]
19. Macular hole after injection of dexamethasone intravitreal implant for macular oedema due to central retinal vein occlusion.
De Benedetto U; Battaglia Parodi M; Knutsson KA; Lattanzio R; Bandello F; Iacono P
Acta Ophthalmol; 2013 Feb; 91(1):e75-7. PubMed ID: 22863290
[No Abstract] [Full Text] [Related]
20. Rebound effect after intravitreal dexamethasone implant for the treatment of macular edema secondary to central retinal vein occlusion.
Parodi MB; Iacono P; De Benedetto U; Cascavilla M; Bandello F
J Ocul Pharmacol Ther; 2012 Dec; 28(6):566-8. PubMed ID: 22746671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
